The IPOX® Week #634
IPOX® INDEXES PERFORMANCE REVIEW
The IPOX® Indexes recorded big declines during U.S. expiration week as asset allocation shifts away from (unseasoned) growth stocks continued unabated, as yields surged amid further FED tightening fears ahead of earnings, equity risk (VIX: +12.18%) spiked and the U.S. dollar rose.
In the U.S., e.g., the IPOX® 100 U.S. (ETF: FPX), gauge for the performance of a diversified basked of large U.S. New Listings and IPO M&A by applying the IPOX® Indexes Technology, slumped by -7.41% to -34.06% YTD, in line with U.S. small-caps (RTY US: -7.48%), lagging U.S. large-caps (SPX) and the Nasdaq 100 (NDX).
Tough sentiment extended to deals abroad with big declines in Europe and across Asia-Pacific pressuring the IPOX® International (ETF: FPXI) to a loss of -5.61% outperforming its benchmarks for a third week in a row. Big declines in stocks in the Energy and Industrial sector towards the weekend further pressured other IPOX® Indexes, including the IPO M&A focused IPOX® Growth Infusion (GNDX).
Click to download the latest issue
